Momelotinib treatment‐emergent neuropathy: prevalence, risk factors and outcome in 100 patients with myelofibrosis von Abdelrahman, Ramy A., Begna, Kebede H., Al‐Kali, Aref, Hogan, William J., Litzow, Mark R., Pardanani, Animesh, Tefferi, Ayalew

Volltext

Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis von Pardanani, Animesh, Finke, Christy, Abdelrahman, Ramy A., Lasho, Terra L., Tefferi, Ayalew

Volltext

ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis von Pardanani, Animesh D., Lasho, Terra L., Finke, Christy, Zblewski, Darci L., Abdelrahman, Ramy A., Wassie, Emnet A., Gangat, Naseema, Hanson, Curtis A., Ketterling, Rhett P., Tefferi, Ayalew

Volltext

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs von van den Anker, John N., McCune, Susan, Annaert, Pieter, Baer, Gerri R., Mulugeta, Yeruk, Abdelrahman, Ramy, Wu, Kunyi, Krudys, Kevin M., Fisher, Jeffrey, Slikker, William, Chen, Connie, Burckart, Gilbert J., Allegaert, Karel

Volltext

Patient Reported Symptoms and Tryptase Levels in WHO-Defined Systemic Mastocytosis (SM) Versus Mast Cell Activation Syndrome (MCAS) Versus Neither von Zblewski, Darci, Abdelrahman, Ramy A., Chen, Dong, Butterfield, Joseph H., Tefferi, Ayalew, Pardanani, Animesh

Volltext

Momelotinib Treatment-Associated Neuropathy: Prevalence, Risk Factors and Outcome in 100 Patients with Myelofibrosis von Abdelrahman, Ramy A., Begna, Kebede, Al-Kali, Aref, Hogan, William J., Litzow, Mark, Pardanani, Animesh, Tefferi, Ayalew

Volltext

Serum Ferritin Level At Referral Provides Independent Prognostic Information For Overall Survival In Primary Myelofibrosis von Pardanani, Animesh D., Lasho, Terra L, Finke, Christy, Abdelrahman, Ramy A., Hanson, Curtis A., Tefferi, Ayalew

Volltext

CD123 Immunostaining in Systemic Mastocytosis: Differential Expression in Disease Subgroups and Potential Prognostic Value von Pardanani, Animesh, Reichard, Kaaren, Zblewski, Darci, Abdelrahman, Ramy, Wassie, Emnet, Morice, William G., Brooks, Christopher L., Hanson, Curtis A., Tefferi, Ayalew, Chen, Dong

Volltext

ASXL1 and CBL Mutations Are Independently Predictive of Inferior Survival in Advanced Systemic Mastocytosis von Pardanani, Animesh, Lasho, Terra L., Finke, Christy, Zblewski, Darci, Abdelrahman, Ramy, Wassie, Emnet, Gangat, Naseema, Hanson, Curtis A., Ketterling, Rhett P., Tefferi, Ayalew

Volltext

Genetic Determinants of Response and Survival in Momelotinib Treated Myelofibrosis Patients von Pardanani, Animesh, Abdelrahman, Ramy A., Finke, Christy, Lasho, Terra L, Begna, Kebede, Al-Kali, Aref, Hogan, William J., Litzow, Mark R., Hanson, Curtis A., Ketterling, Rhett, Tefferi, Ayalew

Volltext

Momelotinib Therapy for Myelofibrosis: Impact on Long-Term Survival and Genotype Correlations von Tefferi, Ayalew, Abdelrahman, Ramy, Finke, Christy, Lasho, Terra L., Begna, Kebede H., Al-Kali, Aref, Hogan, William J, Litzow, Mark R, Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh

Volltext

Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs von van den Anker, John N, McCune, Susan, Annaert, Pieter, Baer, Gerri R, Mulugeta, Yeruk, Abdelrahman, Ramy, Wu, Kunyi, Krudys, Kevin M, Fisher, Jeffrey, Slikker, William, Chen, Connie, Burckart, Gilbert J, Allegaert, Karel

Volltext

Retrospective Comparison Of Survival and Leukemic Transformation In Myelofibrosis Patients Treated With Ruxolitinib Versus Momelotinib Versus Fedratinib Versus Pomalidomide von Pardanani, Animesh, Abdelrahman, Ramy A., Begna, Kebede, Zblewski, Darci, Al-Kali, Aref, Patnaik, Mrinal M., Hogan, William, Hanson, Curtis A., Litzow, Mark R., Tefferi, Ayalew

Volltext

Baseline Spleen Size and Mutations Involving ASXL1 and SRSF2 Predict Survival and Treatment Response In JAK Inhibitor Treated Myelofibrosis Patients von Pardanani, Animesh, Abdelrahman, Ramy A, Begna, Kebede, Zblewski, Darci, Al-Kali, Aref, Patnaik, Mrinal M., Hogan, William, Lasho, Terra L, Finke, Christy, Hanson, Curtis A., Litzow, Mark R., Tefferi, Ayalew

Volltext

Clonal Evolution As Determined By Sequential Bone Marrow Karyotype Analysis During JAK Inhibitor Therapy For Myelofibrosis: Impact On Treatment Response and Overall and Leukemia-Fr... von Abdelrahman, Ramy A., Begna, Kebede, Zblewski, Darci, Al-Kali, Aref, Patnaik, Mrinal M., Hogan, William, Knudson, Ryan A, Ketterling, Rhett P, Hanson, Curtis A., Litzow, Mark R., Tefferi, Ayalew, Pardanani, Animesh

Volltext

Towards Formulation of Highly Acidic Active Ingredients: Development of Clinically Effective Concentrated Trichloroacetic Acid Gel for Wart Management von Helmy, Abdelrahman M., Ahmed, Shimaa Shehata, Sabaa, Ramy M. El, Abdel-Wahab, Hossam M., Abouelmagd, Sara A.

Volltext

Phenotype-Genotype Correlations and Distribution of Key Virulence Factors in Enterococcus faecalis Isolated from Patients with Urinary Tract Infections von Hashem, Yomna A., Abdelrahman, Khaled A., Aziz, Ramy K.

Volltext

Gut microbiome alterations in patients with stage 4 hepatitis C von Aly, AbdelRahman Mahmoud, Adel, AbdelReheem, El-Gendy, Ahmed Osama, Essam, Tamer M, Aziz, Ramy K

Volltext

Synthesis, antimicrobial activity, and sustainable release of novel α-aminophosphonate derivatives loaded carrageenan cryogel von Elsherbiny, Dalia A., Abdelgawad, Abdelrahman M., El-Naggar, Mehrez E., El-Sherbiny, Ramy A., El-Rafie, Mohamed H., El-Sayed, Ibrahim El-Tantawy

Volltext

Beneficial effect of trimetazidine on folic acid‐induced acute kidney injury in mice: Role of HIF‐1α/HO‐1 von Abdelrahman, Rehab S., Abdelsalam, Ramy A., Zaghloul, Marwa S.

Volltext